11982
J. Am. Chem. Soc. 1996, 118, 11982-11983
A New Strategy for Stereocontrol of Cation-Olefin
Cyclization. The First Chemical Emulation of the
A/B-trans-9,10-syn-Folding Pathway of Steroid
Biosynthesis from 2,3-Oxidosqualene
E. J. Corey* and Harold B. Wood, Jr.
Department of Chemistry and Chemical Biology
HarVard UniVersity, Cambridge, Massachusetts 02138
ReceiVed September 19, 1996
The enzymic cyclization of (S)-2,3-oxidosqualene (1) to the
protosterol cation (2)1,2 has never been emulated in a chemical
system, in part because the A/B-trans, 9,10-syn, B/C-trans
stereochemistry of 2, which requires boat geometry for the B
ring, is several kcal/mol less stable than the alternative trans-
anti-trans A/B/C arrangement. In general, chemically conducted
Figure 1. X-ray crystal structure of TBS-enol ether 7.
cation-olefin cyclizations have led to trans-anti-trans type fused
ring systems (triterpene folding) exclusively.1a,3 We report
herein on a substrate design which favors cyclization to A/B-
trans, 9,10-syn product (steroid numbering) and which suggests
a new approach to the control of stereochemistry and olefinic
face selectivity in cation-olefin cyclizations.
equiv of tert-butyldimethylsilyl triflate, TBSOTf, and 2.3 equiv
of 2,6-lutidine in THF at -78 °C for 1 h), (2) selective
hydrogenation of the 14,15-double bond (H2, Pd-C, EtOH, 25
°C, 3 h), (3) oxidative cleavage of the C(7) exocyclic vinyl ether
to form 6 (0.05 equiv of RuCl3, 4 equiv of NaIO4 in CCl4-
CH3CN-H2O at 25 °C for 1.5 h), and (4) transformation of
ketone 6 to the enol ether 7 (1.3 equiv of TBSOTf and 2 equiv
of KHMDS in THF at -78 °C for 45 min).
A crystal of 7 was subjected to X-ray crystallographic analysis
which revealed the three-dimensional structure shown in Figure
1.7 The structure of 7 involves the syn-relationship between
the H at C(9) and the CH3 at C(10) and A/B-trans geometry in
common with the protosterol system. The formation of 7
therefore must involve the same olefinic face selectivity (i.e.,
substrate folding) which is involved in forming the A- and
B-rings during sterol biosynthesis. To the best of our knowledge
this is the first time that this stereochemical pathway has been
demonstrated for a non-enzymic cation-olefin cyclization. The
cis-fusion of the B- and C-rings, which provides a clear
indication that C-ring formation is not concerted with B-ring
closure, reflects the preferred face selectivity for cation-olefin
closure to form the C-ring in this particular system. Evidently,
the bicyclic B-ring cation 8 is a discrete intermediate, and attack
by the terminating π-system occurs preferentially at the R-face
of C(8) of the bicyclic oxaallylic cation. That mode of closure
also controls the C/D-ring fusion of 7 to be cis.
The specific substrate that was the focus of this investigation
was the chiral oxirane 4, which was synthesized as a 1:1 mixture
of E- and Z-isomers4,5 at the vinyl trifluoroethyl ether subunit
by Wittig olefination of the corresponding ketone (3) (Ph3P+-
CH2OCH2CF3 Br-, potassium tert-amyl oxide, C7H8, 25 °C,
4.5 h). Treatment of the 1:1 mixture of E- and Z-4 with
MeAlCl2 (2 equiv) in CH2Cl2 at -95 °C for 1 h produced a
single tetracyclic hydroxy R,â-enone (5) which was obtained
pure in 40% yield after flash column chromatography on silica
gel. The structure of 5 was determined unambiguously as
described below.6 It is likely that 5 arises from the E-form of
4 because of the correspondence of vinyl ether geometry. It
may also be that tetracyclic products are not formed from the
Z-form of 4 because such structures would be severely
destabilized by steric repulsion between C(15) of the D-ring
and the trifluoroethoxy group. On the basis of this assumption,
the yield of the cyclization product would be 80%.
The oily cyclization product 5 was converted to the crystalline
tetracyclic ketone bis-silyl ether 7, mp 145.5-146 °C, by the
following sequence: (1) silylation of the 3-hydroxyl group (1.3
(1) (a) Johnson, W. S. Tetrahedron 1991, 47, xi. (b) Abe, I.; Rohmer,
M.; Prestwich, G. D. Chem. ReV. 1993, 93, 2189.
(2) (a) Corey, E. J.; Virgil, S. C. J. Am. Chem. Soc. 1991, 113, 4025.
(b) Corey, E. J.; Virgil, S. C.; Sarshar, S. J. Am. Chem. Soc. 1991, 113,
8171. (c) Corey, E. J.; Virgil, S. C.; Cheng, H.; Baker, C. H.; Matsuda, S.
P. T.; Singh, V.; Sarshar, S. J. Am. Chem. Soc. 1995, 117, 11819.
(3) (a) Sutherland, J. K. In ComprehensiVe Organic Synthesis; Trost, B.
M., Fleming, I., Eds.; Pergamon Press: Oxford, 1991; Vol. 3, p 341. (b)
Taylor, S. K. Org. Prep. Proced. Intl. 1992, 24, 245. (c) Corey, E. J.; Lee,
J. J. Am. Chem. Soc. 1993, 115, 8873. (d) Corey, E. J.; Lee, J.; Liu, D. R.
Tetrahedron Lett. 1994, 35, 9149. (e) Corey, E. J.; Lin, S. J. Am. Chem.
Soc. 1996, 118, 8765.
(4) The 1:1 mixture of E- and Z-isomers of 4 could not be separated
chromatographically. Further research is planned toward the objective of
the stereoselective conversion of 3 to the E-isomer of 4.
We believe that there is a logical mechanistic basis for the
realization of the biomimetic A/B-trans, 9,10-syn cyclization
(5) The methyl vinyl ether analog of 4 was not a satisfactory substrate
for cyclization because the basicity of the methoxy group interfered by
coordinating to the Lewis acidic reagent.
(7) The coordinates of 7 and other X-ray data can be obtained, on request,
from the Director, Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge, CB2 1EZ, U.K.
(6) The E-geometry of the C(7) exocyclic double bond of 5 was also
1
revealed by H NMR NOE data.
S0002-7863(96)03292-1 CCC: $12.00 © 1996 American Chemical Society